Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiaoen Wang
Targeting HER2 Aberrations in Non-Small Cell Lung Cancer With Osimertinib
Clinical Cancer Research
Cancer Research
Oncology
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer
Oncotarget
Oncology
Osimertinib (AZD9291) Increases Radio‑sensitivity in EGFR T790M Non‑small Cell Lung Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
P1.03-02 Analysis of SMAD4 Aberrations in Chinese Patients With Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation
Cancers
Cancer Research
Oncology
Targeting SLC1a5-mediated Glutamine Dependence in Non-Small Cell Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
P2.13-42 Osimertinib Treatment for Patients With EGFR Exon 20 Insertion Positive Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Osimertinib in the Treatment of Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy
Lung Cancer: Targets and Therapy
Oncology
Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?
Current Respiratory Care Reports
Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology